References
Morton DL, Thompson JF, Cochran AJ, Essner R, Elashoff R. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in clinical stage 1 melanoma (abstract). J Clin Oncol 2005; 23:710
Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (in press)
Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early stage melanoma. Accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg 2005; 242:302–11
Dewar DJ, Newell B, Green MA, et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22:3345–9
Palmieri G, Ascierto P, Cossu A, et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001; 23:1437–43
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henderson, M.A. Completion Lymphadenectomy for Melanoma Patients With a Positive Sentinel Node Biopsy Remains Standard of Care. Ann Surg Oncol 13, 761–763 (2006). https://doi.org/10.1245/ASO.2006.09.915
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.09.915